These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
714 related articles for article (PubMed ID: 32285726)
21. A distinct pre-existing inflammatory tumour microenvironment is associated with chemotherapy resistance in high-grade serous epithelial ovarian cancer. Koti M; Siu A; Clément I; Bidarimath M; Turashvili G; Edwards A; Rahimi K; Mes-Masson AM; Squire JA Br J Cancer; 2015 Mar; 112(7):1215-22. PubMed ID: 25826225 [TBL] [Abstract][Full Text] [Related]
22. Stage-specific embryonic antigen 4 expression in epithelial ovarian carcinoma. Ye F; Li Y; Hu Y; Zhou C; Hu Y; Chen H Int J Gynecol Cancer; 2010 Aug; 20(6):958-64. PubMed ID: 20683402 [TBL] [Abstract][Full Text] [Related]
23. Somatic genetic alterations in synchronous and metachronous low-grade serous tumours and high-grade carcinomas of the adnexa. Murali R; Selenica P; Brown DN; Cheetham RK; Chandramohan R; Claros NL; Bouvier N; Cheng DT; Soslow RA; Weigelt B; McCluggage WG Histopathology; 2019 Mar; 74(4):638-650. PubMed ID: 30565721 [TBL] [Abstract][Full Text] [Related]
24. Nicotinamide N-methyltransferase expression and its association with phospho-Akt, p53 expression, and survival in high-grade endometrial cancer. Akar S; Harmankaya İ; Uğraş S; Çelik Ç Turk J Med Sci; 2019 Oct; 49(5):1547-1554. PubMed ID: 31652035 [TBL] [Abstract][Full Text] [Related]
25. Decreased Eph receptor‑A1 expression is related to grade in ovarian serous carcinoma. Jin Y; Zou Y; Wan L; Lu M; Liu Y; Huang G; Wang J; Xi Q Mol Med Rep; 2018 Apr; 17(4):5409-5415. PubMed ID: 29393455 [TBL] [Abstract][Full Text] [Related]
26. Clinical significance of miRNA-21, -103, -129, -150 in serous ovarian cancer. Wilczyński M; Żytko E; Danielska J; Szymańska B; Dzieniecka M; Nowak M; Malinowski J; Owczarek D; Wilczyński JR Arch Gynecol Obstet; 2018 Mar; 297(3):741-748. PubMed ID: 29335784 [TBL] [Abstract][Full Text] [Related]
27. Expression of palladin is associated with disease progression in metastatic high-grade serous carcinoma. Davidson B; Bock AJ; Holth A; Nymoen DA Cytopathology; 2020 Nov; 31(6):572-578. PubMed ID: 32741023 [TBL] [Abstract][Full Text] [Related]
28. Nicotinamide N-methyltransferase enhances chemoresistance in breast cancer through SIRT1 protein stabilization. Wang Y; Zeng J; Wu W; Xie S; Yu H; Li G; Zhu T; Li F; Lu J; Wang GY; Xie X; Zhang J Breast Cancer Res; 2019 May; 21(1):64. PubMed ID: 31101119 [TBL] [Abstract][Full Text] [Related]
29. Proteomics reveals NNMT as a master metabolic regulator of cancer-associated fibroblasts. Eckert MA; Coscia F; Chryplewicz A; Chang JW; Hernandez KM; Pan S; Tienda SM; Nahotko DA; Li G; Blaženović I; Lastra RR; Curtis M; Yamada SD; Perets R; McGregor SM; Andrade J; Fiehn O; Moellering RE; Mann M; Lengyel E Nature; 2019 May; 569(7758):723-728. PubMed ID: 31043742 [TBL] [Abstract][Full Text] [Related]
30. Combination of TP53 and AGR3 to distinguish ovarian high-grade serous carcinoma from low-grade serous carcinoma. Qiu C; Wang Y; Wang X; Zhang Q; Li Y; Xu Y; Jin C; Bu H; Zheng W; Yang X; Lu N; Kong B Int J Oncol; 2018 Jun; 52(6):2041-2050. PubMed ID: 29620196 [TBL] [Abstract][Full Text] [Related]
31. Validity and prognostic significance of sperm protein 17 as a tumor biomarker for epithelial ovarian cancer: a retrospective study. Brunette LL; Mhawech-Fauceglia PY; Ji L; Skeate JG; Brand HE; Lawrenson K; Walia S; Chiriva-Internati M; Groshen S; Roman LD; Kast WM; Da Silva DM BMC Cancer; 2018 Oct; 18(1):970. PubMed ID: 30309325 [TBL] [Abstract][Full Text] [Related]
32. Mammary serine protease inhibitor and CD138 immunohistochemical expression in ovarian serous and clear cell carcinomas. Hasby EA Tumour Biol; 2016 Apr; 37(4):4889-900. PubMed ID: 26526579 [TBL] [Abstract][Full Text] [Related]
33. Overexpression of ICAM-1 Predicts Poor Survival in High-Grade Serous Ovarian Carcinoma: A Study Based on TCGA and GEO Databases and Tissue Microarray. Wang S; Yin C; Zhang Y; Zhang L; Tao L; Liang W; Pang L; Fu R; Ding Y; Li F; Jia W Biomed Res Int; 2019; 2019():2867372. PubMed ID: 31312656 [TBL] [Abstract][Full Text] [Related]
34. Accumulation of Nicotinamide N-Methyltransferase (NNMT) in Cancer-associated Fibroblasts: A Potential Prognostic and Predictive Biomarker for Gastric Carcinoma. Zhang L; Song M; Zhang F; Yuan H; Chang W; Yu G; Niu Y J Histochem Cytochem; 2021 Mar; 69(3):165-176. PubMed ID: 33283625 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of MTAP immunohistochemistry loss of expression in ovarian serous borderline tumors as a potential marker for prognosis and progression. Nilforoushan N; Moatamed NA Ann Diagn Pathol; 2020 Oct; 48():151582. PubMed ID: 32866902 [TBL] [Abstract][Full Text] [Related]
36. Clinicopathological significance of DEK overexpression in serous ovarian tumors. Han S; Xuan Y; Liu S; Zhang M; Jin D; Jin R; Lin Z Pathol Int; 2009 Jul; 59(7):443-7. PubMed ID: 19563407 [TBL] [Abstract][Full Text] [Related]
38. Long Non-coding RNA Yim GW; Kim HJ; Kim LK; Kim SW; Kim S; Nam EJ; Kim YT Cancer Res Treat; 2017 Jul; 49(3):656-668. PubMed ID: 27737536 [TBL] [Abstract][Full Text] [Related]
39. Quantitative analysis of follicle-stimulating hormone receptor in ovarian epithelial tumors: a novel approach to explain the field effect of ovarian cancer development in secondary mullerian systems. Wang J; Lin L; Parkash V; Schwartz PE; Lauchlan SC; Zheng W Int J Cancer; 2003 Jan; 103(3):328-34. PubMed ID: 12471615 [TBL] [Abstract][Full Text] [Related]
40. High expression of NQO1 is associated with poor prognosis in serous ovarian carcinoma. Cui X; Li L; Yan G; Meng K; Lin Z; Nan Y; Jin G; Li C BMC Cancer; 2015 Apr; 15():244. PubMed ID: 25885439 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]